$6.49 Billion is the total value of Hillhouse Capital Management's 60 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 58.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $503,076,000 | +50258.0% | 3,570,449 | +38449.4% | 7.75% | +40710.5% |
| PCLN | Buy | PRICELINE GRP INC | $477,230,000 | +5.5% | 255,132 | +0.4% | 7.36% | -16.1% |
| CTRP | Buy | CTRIP COM INTL LTD | $259,188,000 | +163.7% | 4,812,246 | +140.6% | 4.00% | +109.6% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $167,433,000 | +235.1% | 3,720,726 | +172.6% | 2.58% | +166.4% |
| ZTO | New | ZTO EXPRESS CAYMAN INCsponsored adr | $158,961,000 | – | 11,386,920 | +100.0% | 2.45% | – |
| YUMC | Buy | YUM CHINA HLDGS INC | $90,807,000 | +51.0% | 2,302,989 | +4.1% | 1.40% | +20.1% |
| CBPO | Buy | CHINA BIOLOGIC PRODS INC | $85,235,000 | +224.0% | 753,624 | +186.8% | 1.31% | +157.6% |
| TRIP | Buy | TRIPADVISOR INC | $62,371,000 | +3.7% | 1,632,757 | +17.1% | 0.96% | -17.7% |
| FGEN | Buy | FIBROGEN INC | $56,525,000 | +129.3% | 1,750,000 | +75.0% | 0.87% | +82.2% |
| BEDU | New | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $51,170,000 | – | 4,300,000 | +100.0% | 0.79% | – |
| BITA | New | BITAUTO HLDGS LTDsponsored ads | $32,315,000 | – | 1,124,017 | +100.0% | 0.50% | – |
| NTES | New | NETEASE INCsponsored adr | $30,018,000 | – | 99,850 | +100.0% | 0.46% | – |
| YY | Buy | YY INC | $20,604,000 | +30.1% | 355,057 | +3.4% | 0.32% | +3.6% |
| TWTR | Buy | TWITTER INC | $19,997,000 | +3426.8% | 1,119,000 | +2852.5% | 0.31% | +2700.0% |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $16,709,000 | +26.0% | 49,603 | +22.4% | 0.26% | +0.4% |
| BRKA | Buy | BERKSHIRE HATHAWAY INC DELcl a | $15,282,000 | +52.9% | 60 | +50.0% | 0.24% | +21.6% |
| SCHW | Buy | SCHWAB CHARLES CORP NEW | $14,597,000 | +24.7% | 339,782 | +18.4% | 0.22% | -0.9% |
| LBTYK | Buy | LIBERTY GLOBAL PLC | $13,186,000 | +51.3% | 422,897 | +70.0% | 0.20% | +20.1% |
| MCO | Buy | MOODYS CORP | $10,945,000 | +35.8% | 89,949 | +25.0% | 0.17% | +8.3% |
| VRSN | Buy | VERISIGN INC | $10,901,000 | +19.0% | 117,264 | +11.5% | 0.17% | -5.6% |
| WB | New | WEIBO CORPsponsored adr | $9,440,000 | – | 142,020 | +100.0% | 0.14% | – |
| CLSD | Buy | CLEARSIDE BIOMEDICAL INC | $8,199,000 | +20.8% | 900,000 | +5.3% | 0.13% | -4.5% |
| GTHX | New | G1 THERAPEUTICS INC | $7,848,000 | – | 450,000 | +100.0% | 0.12% | – |
| URGN | New | UROGEN PHARMA LTD | $6,363,000 | – | 352,300 | +100.0% | 0.10% | – |
| TSRO | New | TESARO INC | $4,153,000 | – | 29,697 | +100.0% | 0.06% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $3,000,000 | – | 120,000 | +100.0% | 0.05% | – |
| VIPS | New | VIPSHOP HLDGS LTDsponsored adr | $831,000 | – | 78,786 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.